Alecensa 150 MG capsule UU 240S
Ended Awarded
- Contract number
- SPE2DX25F6XKH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $38,347
Award facts
- Contract value 100% obligated
- $38,346.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Defense Logistics Agency (DLA), acting through the Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. on June 9, 2025, for the supply of Alecensa 150 mg capsules in quantities of 240 units. This firm fixed-price delivery order, valued at $38,346.96, represents a single task issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which carries a maximum value of $499,999,999 and extends through November 2026. The delivery order is scheduled for completion by July 1, 2025, with fulfillment occurring at the contractor's location in Park Ridge, Illinois. No small business set-aside designation was applied to this award.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler established in Park Ridge, Illinois, serves as the prime contractor and sole awardee. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare facilities nationwide. Alecensa is an oncology medication used in the treatment of non-small cell lung cancer, reflecting the contractor's demonstrated expertise in supplying specialized pharmaceutical products to federal military health systems. This award reflects DMS Pharmaceutical Group's established position within the federal pharmaceutical supply chain and its ability to respond rapidly to medical supply requirements across the Defense Logistics Agency's network.
Quick answers
Who was awarded contract SPE2DX25F6XKH?
SPE2DX25F6XKH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 9, 2025.
How much is contract SPE2DX25F6XKH worth?
The government has obligated $38,347 on SPE2DX25F6XKH.
Is contract SPE2DX25F6XKH an order under another contract?
Yes. SPE2DX25F6XKH is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XKH competed?
The extent of competition for SPE2DX25F6XKH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award